[New aminoglycoside antibiotics].
D000583:Amikacin / Q000096:biosynthesis / Q000494:pharmacology / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D004352:Drug Resistance, Microbial; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D006801:Humans; D007612:Kanamycin / Q000031:analogs & derivatives*; D011552:Pseudomonas Infections / Q000188:drug therapy; D014031:Tobramycin / Q000096:biosynthesis / Q000494:pharmacology / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D007612:Kanamycin; D000583:Amikacin; D014031:Tobramycin
Nowe antybiotyki aminoglikozydowe.